4,0
1 set 2025
Ex dipendente
Boston, MA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
- data sciences approaches - RPM market in provider and life sciences was exploratory in 2023
Svantaggi
- broke up company into multiple parts and sold